Cargando…
Efficacy and safety of chinese herbal medicine for treating mild or moderate COVID-19: A systematic review and meta-analysis of randomized controlled trials and observational studies
Background: The coronavirus disease 2019 (COVID-19) is still a pandemic globally, about 80% of patients infected with COVID-19 were mild and moderate. Chinese herbal medicine (CHM) has played a positive role in the treatment of COVID-19, with a certain number of primary studies focused on CHM in man...
Autores principales: | Zhu, Hongfei, Li, Mengting, Tian, Chen, Lai, Honghao, Zhang, Yuqing, Shi, Jiaheng, Shi, Nannan, Zhao, Hui, Yang, Kehu, Shang, Hongcai, Sun, Xin, Liu, Jie, Ge, Long, Huang, Luqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504662/ https://www.ncbi.nlm.nih.gov/pubmed/36160412 http://dx.doi.org/10.3389/fphar.2022.988237 |
Ejemplares similares
-
Role of Traditional Chinese Medicine in Treating Severe or Critical COVID-19: A Systematic Review of Randomized Controlled Trials and Observational Studies
por: Li, Mengting, et al.
Publicado: (2022) -
Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis
por: Wang, Qi, et al.
Publicado: (2021) -
The efficacy and safety of Chinese herbal medicine in the treatment of painful diabetic neuropathy: A systematic review and meta-analysis
por: Song, Min, et al.
Publicado: (2023) -
Benefits and Safety of Chinese Herbal Medicine in Treating Psoriasis: An Overview of Systematic Reviews
por: Zhang, Jie, et al.
Publicado: (2021) -
Chinese Herbal Medicine for Mild Cognitive Impairment: A Systematic Review of Randomized Controlled Trials
por: Liang, Ning, et al.
Publicado: (2022)